Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
27,315,628
-
Share change
-
+251,797
-
Total reported value
-
$1,237,695,092
-
Put/Call ratio
-
112%
-
Price per share
-
$45.28
-
Number of holders
-
161
-
Value change
-
+$11,132,499
-
Number of buys
-
59
-
Number of sells
-
76
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2016
As of 31 Dec 2016,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,315,628 shares.
The largest 10 holders included
Fisher Asset Management, LLC, COMMONWEALTH BANK OF AUSTRALIA, ROYAL BANK OF CANADA, AQR CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, VONTOBEL ASSET MANAGEMENT INC, BlackRock Group LTD, JPMORGAN CHASE & CO, DIMENSIONAL FUND ADVISORS LP, and HSBC HOLDINGS PLC.
This page lists
161
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.